Acorda Therapeutics
ACOR
#11271
Rank
NZ$1.45 M
Marketcap
NZ$1.17
Share price
0.00%
Change (1 day)
-95.64%
Change (1 year)

EPS for Acorda Therapeutics (ACOR)

EPS in 2023 (TTM): NZ-$17.99

According to Acorda Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ-$89.29. In 2022 the company made an earnings per share (EPS) of NZ-$156.53 an increase over its 2021 EPS that were of NZ-$354.23.

EPS history for Acorda Therapeutics from 2006 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ-$17.99-88.51%
2022NZ-$156.53-55.81%
2021NZ-$354.23-16.13%
2020NZ-$422.38-65.51%
2019NZ-$1,225-898.61%
2018NZ$153.33-114.88%
2017NZ-$1,031536.84%
2016NZ-$161.85-392.31%
2015NZ$55.37-39.53%
2014NZ$91.574.88%
2013NZ$87.32-89.54%
2012NZ$834.82409.09%
2011NZ$163.98-333.33%
2010NZ-$70.28-85.14%
2009NZ-$472.781.37%
2008NZ-$466.3951.03%
2007NZ-$308.80-68.27%
2006NZ-$973.24

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sarepta Therapeutics
SRPT
NZ-$4.67-94.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
NZ-$0.35-99.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Affimed
AFMD
NZ-$9.28-89.61%๐Ÿ‡ฉ๐Ÿ‡ช Germany
BioMarin Pharmaceutical
BMRN
NZ$0.67-100.76%๐Ÿ‡บ๐Ÿ‡ธ USA